You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《美股業績》吉利德科學(GILD.US)季績遜預期 瑞德西韋銷售跌63%
阿思達克 04-28 08:58
美國藥廠吉利德科學(Gilead Sciences)(GILD.US)公布季績。季度純利10.1億美元,去年因就研發減值27億美元,去年同期純利為1,900萬美元。每股季度攤薄純利80美仙,經調整後為1.37美元,低於市場預期的1.54美元。季度派息每股75美仙。季度收入按年跌3.6%至63.52億美元。 新冠藥物瑞德西韋季度銷售按年跌63%至5.73億美元,市場預期為6.98億美元。愛滋病治療銷售按年升13%至41.9億美元。 吉利德科學股價在延長交易時段升0.5%,報84美元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account